Sector Chart Myriad Genetics, Inc.
Stocks
MYGN
US62855J1043
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
21:00:00 18/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 3.890 USD | -6.04% |
|
+13.74% | -36.75% |
| 09-16 | Myriad Genetics, Inc. Announces Management Changes | CI |
| 09-09 | UBS Adjusts Price Target on Myriad Genetics to $3.60 From $6, Keeps Neutral Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Diagnostic & Testing Substances
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 372M | - | ||||
| 24.07B | - | ||||
| 9.98B | - | ||||
| 9.66B | |||||
| 8.47B | |||||
| 6.56B |
- Stock Market
- Stocks
- MYGN Stock
- Charts Myriad Genetics, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
